New, potentially important concerns have been raised about bioprosthetic aortic valves, both those implanted during surgery and those during a catheter-based procedure (TAVR). Investigators from three separate groups reported on their troubling findings in a paper published in the New England Journal of Medicine. The article was accompanied by both an editorial and a perspective from the FDA….
Recent Comments